Clinical Trials Browser

Phase 3 × Recruiting × Tegafur × Clear all

NCT04415853 2025-05-18

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Phase 3 Recruiting

Gastrointestinal

Esophageal Neoplasms

NCT03941561 2019-05-31

S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms